FrameworkLTC
FrameworkLTC offers a comprehensive and adaptable platform that streamlines all manual processes, enabling LTC pharmacies to concentrate on their primary goal: enhancing patient well-being. By transitioning from manual operations to automation, businesses can grow while optimizing their profit margins. Tailoring services to meet the unique requirements of each facility can also enhance partnerships. Our software, designed with a facility-focused approach, empowers you to deliver exceptional service to every patient, section, and establishment. Facilities can easily manage billing, track order statuses, and handle returns based on your established protocols. Your facilities will find great value in the insightful reports you provide. Additionally, automate the prescription refill and reorder process to ensure nothing is overlooked during production. By leveraging this technology, you can significantly improve operational efficiency and patient satisfaction.
Learn more
SenseIP
senseIP is a revolutionary AI-based platform designed to simplify patent research, drafting, filing, and management. It empowers inventors—whether individuals, startups, or corporations—to file robust patents with ease and at a fraction of the cost of traditional legal services. Using AI trained on over 100 million patents, senseIP offers efficient prior art searches, error-free drafting, and quick filing, providing a seamless process from idea to intellectual property protection. With senseIP, inventors can complete the entire patent process for a flat fee, saving significant time and money.
Learn more
Healnet
The realm of rare diseases frequently suffers from inadequate research, leading to a lack of vital insights necessary for successful drug discovery efforts. Our advanced AI platform, Healnet, tackles these challenges by analyzing extensive datasets related to drugs and diseases, revealing novel connections that could pave the way for new treatment options. By employing state-of-the-art technologies during both the discovery and development stages, we can manage several phases at once and on a considerable scale. The traditional methodology, which usually concentrates on one disease, target, and drug, is an overly simplistic model that many pharmaceutical companies continue to follow. The upcoming era of drug discovery is set to be revolutionized by AI, which emphasizes concurrent operations and a flexibility that allows for exploration beyond rigid hypotheses, effectively merging the three fundamental aspects of drug discovery into a unified approach. This innovative framework not only boosts productivity but also encourages inventive thinking in addressing intricate health issues. As we move forward, the integration of AI in drug development will likely reshape how the industry approaches the challenges of rare diseases.
Learn more
Atomwise
Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.
Learn more
